These studies have highlighted the role of RBX1 in cell growth and the known dysfunction of the SCF E3 ubiquitin ligases in various cancers; therefore, we hypothesize that RBX1 overexpression is required for the survival of MM cells and the promotion of drug cytotoxicity. The gene discussed is RBX1; the disease is Miyoshi myopathy.